
Eric Olson
Examiner (ID: 316, Phone: (571)272-9051 , Office: P/1673 )
| Most Active Art Unit | 1623 |
| Art Unit(s) | 1693, 1673, 1623 |
| Total Applications | 1758 |
| Issued Applications | 971 |
| Pending Applications | 175 |
| Abandoned Applications | 632 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 9677164
[patent_doc_number] => 08816074
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2014-08-26
[patent_title] => '2′-fluoro-6′-methylene carbocyclic nucleosides and methods of treating viral infections'
[patent_app_type] => utility
[patent_app_number] => 13/107713
[patent_app_country] => US
[patent_app_date] => 2011-05-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 15
[patent_figures_cnt] => 14
[patent_no_of_words] => 23874
[patent_no_of_claims] => 84
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 3
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13107713
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/107713 | 2′-fluoro-6′-methylene carbocyclic nucleosides and methods of treating viral infections | May 12, 2011 | Issued |
Array
(
[id] => 6090862
[patent_doc_number] => 20110218247
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-09-08
[patent_title] => 'FORMULATIONS OF LOW DOSE DICLOFENAC AND BETA-CYCLODEXTRIN'
[patent_app_type] => utility
[patent_app_number] => 13/106697
[patent_app_country] => US
[patent_app_date] => 2011-05-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 4304
[patent_no_of_claims] => 31
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0218/20110218247.pdf
[firstpage_image] =>[orig_patent_app_number] => 13106697
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/106697 | Formulations of low dose diclofenac and beta-cyclodextrin | May 11, 2011 | Issued |
Array
(
[id] => 7977647
[patent_doc_number] => 08071570
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2011-12-06
[patent_title] => 'Mixtures of polysaccharides derived from heparin, their preparation and pharmaceutical compositions containing them'
[patent_app_type] => utility
[patent_app_number] => 13/103960
[patent_app_country] => US
[patent_app_date] => 2011-05-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 15072
[patent_no_of_claims] => 7
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 133
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/08/071/08071570.pdf
[firstpage_image] =>[orig_patent_app_number] => 13103960
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/103960 | Mixtures of polysaccharides derived from heparin, their preparation and pharmaceutical compositions containing them | May 8, 2011 | Issued |
Array
(
[id] => 8982088
[patent_doc_number] => 08513202
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2013-08-20
[patent_title] => 'Crystalline form of 1-(β-D-glucopyranosyl)-4-methyl-3-[5-(4-fluorophenyl)-2-thienylmethyl]benzene hemihydrate'
[patent_app_type] => utility
[patent_app_number] => 13/103557
[patent_app_country] => US
[patent_app_date] => 2011-05-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 2920
[patent_no_of_claims] => 5
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 39
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13103557
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/103557 | Crystalline form of 1-(β-D-glucopyranosyl)-4-methyl-3-[5-(4-fluorophenyl)-2-thienylmethyl]benzene hemihydrate | May 8, 2011 | Issued |
Array
(
[id] => 9059918
[patent_doc_number] => 08546353
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2013-10-01
[patent_title] => 'Compounds and combinations'
[patent_app_type] => utility
[patent_app_number] => 13/102451
[patent_app_country] => US
[patent_app_date] => 2011-05-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 16
[patent_figures_cnt] => 16
[patent_no_of_words] => 12293
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 23
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13102451
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/102451 | Compounds and combinations | May 5, 2011 | Issued |
Array
(
[id] => 8660079
[patent_doc_number] => 20130040908
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-02-14
[patent_title] => 'SUBSTITUTION DERIVATIVES OF N6-BENZYLADENOSINE-5\' -MONOPHOSPHATE, METHODS OF PREPARATION THEREOF, USE THEREOF AS MEDICAMENTS, AND THERAPEUTIC PREPARATIONS CONTAINING THESE COMPOUNDS'
[patent_app_type] => utility
[patent_app_number] => 13/642905
[patent_app_country] => US
[patent_app_date] => 2011-04-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 11443
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13642905
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/642905 | Substitution derivatives of N6 -benzyladenosine-5′-monophosphate, methods of preparation thereof, use thereof as medicaments, and therapeutic preparations containing these compounds | Apr 27, 2011 | Issued |
Array
(
[id] => 6064899
[patent_doc_number] => 20110201793
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-08-18
[patent_title] => 'PROCESS FOR PRODUCTION OF GLUCOPYRANOSYLOXYPYRAZOLE DERIVATIVE'
[patent_app_type] => utility
[patent_app_number] => 13/093100
[patent_app_country] => US
[patent_app_date] => 2011-04-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 11651
[patent_no_of_claims] => 5
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0201/20110201793.pdf
[firstpage_image] =>[orig_patent_app_number] => 13093100
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/093100 | PROCESS FOR PRODUCTION OF GLUCOPYRANOSYLOXYPYRAZOLE DERIVATIVE | Apr 24, 2011 | Abandoned |
Array
(
[id] => 7500369
[patent_doc_number] => 20110262917
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-10-27
[patent_title] => 'MODIFIED NUCLEOTIDES'
[patent_app_type] => utility
[patent_app_number] => 13/090729
[patent_app_country] => US
[patent_app_date] => 2011-04-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 7940
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0262/20110262917.pdf
[firstpage_image] =>[orig_patent_app_number] => 13090729
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/090729 | Modified nucleotides | Apr 19, 2011 | Issued |
Array
(
[id] => 8441558
[patent_doc_number] => 20120258174
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-10-11
[patent_title] => 'Methods for Treating Bacterial Infection'
[patent_app_type] => utility
[patent_app_number] => 13/085585
[patent_app_country] => US
[patent_app_date] => 2011-04-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 8619
[patent_no_of_claims] => 28
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13085585
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/085585 | Methods for Treating Bacterial Infection | Apr 12, 2011 | Abandoned |
Array
(
[id] => 6177485
[patent_doc_number] => 20110178033
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-07-21
[patent_title] => 'GLUCOPYRANOSYL-SUBSTITUTED PHENYL DERIVATIVES, MEDICAMENTS CONTAINING SUCH COMPOUNDS, THEIR USE AND PROCESS FOR THEIR MANUFACTURE'
[patent_app_type] => utility
[patent_app_number] => 13/079424
[patent_app_country] => US
[patent_app_date] => 2011-04-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 20606
[patent_no_of_claims] => 28
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0178/20110178033.pdf
[firstpage_image] =>[orig_patent_app_number] => 13079424
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/079424 | GLUCOPYRANOSYL-SUBSTITUTED PHENYL DERIVATIVES, MEDICAMENTS CONTAINING SUCH COMPOUNDS, THEIR USE AND PROCESS FOR THEIR MANUFACTURE | Apr 3, 2011 | Abandoned |
Array
(
[id] => 9375807
[patent_doc_number] => 08680071
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2014-03-25
[patent_title] => 'Compounds and pharmaceutical compositions for the treatment of viral infections'
[patent_app_type] => utility
[patent_app_number] => 13/077733
[patent_app_country] => US
[patent_app_date] => 2011-03-31
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 34644
[patent_no_of_claims] => 30
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 6
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13077733
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/077733 | Compounds and pharmaceutical compositions for the treatment of viral infections | Mar 30, 2011 | Issued |
Array
(
[id] => 7487507
[patent_doc_number] => 20110251152
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-10-13
[patent_title] => 'NUCLEOSIDE PHOSPHORAMIDATES'
[patent_app_type] => utility
[patent_app_number] => 13/076552
[patent_app_country] => US
[patent_app_date] => 2011-03-31
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 25
[patent_figures_cnt] => 25
[patent_no_of_words] => 40536
[patent_no_of_claims] => 70
[patent_no_of_ind_claims] => 8
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0251/20110251152.pdf
[firstpage_image] =>[orig_patent_app_number] => 13076552
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/076552 | Nucleoside phosphoramidates | Mar 30, 2011 | Issued |
Array
(
[id] => 8586857
[patent_doc_number] => 20130005678
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-01-03
[patent_title] => 'Methods and Compositions for Treating or Ameliorating Cancer Using Gemcitabine-5\'-Elaidate'
[patent_app_type] => utility
[patent_app_number] => 13/583982
[patent_app_country] => US
[patent_app_date] => 2011-03-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 29597
[patent_no_of_claims] => 23
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13583982
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/583982 | Methods and Compositions for Treating or Ameliorating Cancer Using Gemcitabine-5'-Elaidate | Mar 29, 2011 | Abandoned |
Array
(
[id] => 9889130
[patent_doc_number] => 08975386
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2015-03-10
[patent_title] => 'Crystalline forms of a macrolide, and uses therefor'
[patent_app_type] => utility
[patent_app_number] => 13/636510
[patent_app_country] => US
[patent_app_date] => 2011-03-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 10056
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 33
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13636510
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/636510 | Crystalline forms of a macrolide, and uses therefor | Mar 21, 2011 | Issued |
Array
(
[id] => 8671399
[patent_doc_number] => 20130045937
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-02-21
[patent_title] => 'PARENTERAL FORMULATIONS OF MACROLIDE ANTIBIOTICS'
[patent_app_type] => utility
[patent_app_number] => 13/583556
[patent_app_country] => US
[patent_app_date] => 2011-03-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 13304
[patent_no_of_claims] => 33
[patent_no_of_ind_claims] => 12
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13583556
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/583556 | PARENTERAL FORMULATIONS OF MACROLIDE ANTIBIOTICS | Mar 9, 2011 | Abandoned |
Array
(
[id] => 6088027
[patent_doc_number] => 20110217339
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-09-08
[patent_title] => 'MUCOACTIVE AGENTS FOR TREATING A PULMONARY DISEASE'
[patent_app_type] => utility
[patent_app_number] => 13/043117
[patent_app_country] => US
[patent_app_date] => 2011-03-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 17065
[patent_no_of_claims] => 46
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0217/20110217339.pdf
[firstpage_image] =>[orig_patent_app_number] => 13043117
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/043117 | MUCOACTIVE AGENTS FOR TREATING A PULMONARY DISEASE | Mar 7, 2011 | Abandoned |
Array
(
[id] => 11612555
[patent_doc_number] => 09650404
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2017-05-16
[patent_title] => 'Curcumin derivatives'
[patent_app_type] => utility
[patent_app_number] => 13/581020
[patent_app_country] => US
[patent_app_date] => 2011-02-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 8979
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 8
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13581020
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/581020 | Curcumin derivatives | Feb 24, 2011 | Issued |
Array
(
[id] => 6144545
[patent_doc_number] => 20110130358
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-06-02
[patent_title] => 'METHOD FOR TRANSDIFFERENTIATION OF BODY TISSUES'
[patent_app_type] => utility
[patent_app_number] => 13/023152
[patent_app_country] => US
[patent_app_date] => 2011-02-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 14473
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0130/20110130358.pdf
[firstpage_image] =>[orig_patent_app_number] => 13023152
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/023152 | METHOD FOR TRANSDIFFERENTIATION OF BODY TISSUES | Feb 7, 2011 | Abandoned |
Array
(
[id] => 5973599
[patent_doc_number] => 20110152508
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-06-23
[patent_title] => 'REAGENTS AND METHODS FOR PREPARING LPS ANTAGONIST B1287 AND STEREOISOMERS THEREOF'
[patent_app_type] => utility
[patent_app_number] => 13/021388
[patent_app_country] => US
[patent_app_date] => 2011-02-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 25611
[patent_no_of_claims] => 139
[patent_no_of_ind_claims] => 12
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0152/20110152508.pdf
[firstpage_image] =>[orig_patent_app_number] => 13021388
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/021388 | Reagents and methods for preparing LPS antagonist B1287 and stereoisomers thereof | Feb 3, 2011 | Issued |
Array
(
[id] => 8496465
[patent_doc_number] => 20120295873
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-11-22
[patent_title] => 'BRANCHED SOLUBLE GLUCOSE POLYMERS FOR PERITONEAL DIALYSIS'
[patent_app_type] => utility
[patent_app_number] => 13/575757
[patent_app_country] => US
[patent_app_date] => 2011-02-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9245
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13575757
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/575757 | Branched soluble glucose polymers for peritoneal dialysis | Jan 31, 2011 | Issued |